Bioblast Pharma Ltd.

(ORPN) Trade

Symbol has changed to a new ticker symbol

(ENLV)

By |

Profile

Bioblast Pharma Ltd is an Israel-based development-stage biopharmaceutical company. The firm is focused on the identification, licensing, acquisition, development and commercialization of drugs for rare and ultra-rare genetic and metabolic diseases. It focuses on therapeutic platforms that offer solutions for several diseases that share a common pathophysiological mechanism, which are the functional changes that accompany a particular syndrome or disease. It also focuses on diseases with severe and debilitating manifestations.

Contact Information

Website: bioblastpharma.com
Main Phone: +972 35736632
Address: PO Box 318
Address 2: 15th Floor
State: CT
City / Town: Tel Aviv
Country: ISR
Postal Code: 6100201

Issuer Information

Exchange: NSC
CEO: Fredric D. Price
Employees: 2
NAICS: Pharmaceutical Preparation Manufacturing (325412)


Gathering Data... Please wait

Profile

Bioblast Pharma Ltd is an Israel-based development-stage biopharmaceutical company. The firm is focused on the identification, licensing, acquisition, development and commercialization of drugs for rare and ultra-rare genetic and metabolic diseases. It focuses on therapeutic platforms that offer solutions for several diseases that share a common pathophysiological mechanism, which are the functional changes that accompany a particular syndrome or disease. It also focuses on diseases with severe and debilitating manifestations.

Contact Information

Website: bioblastpharma.com
Main Phone: +972 35736632
Address: PO Box 318
Address 2: 15th Floor
State: CT
City / Town: Tel Aviv
Country: ISR
Postal Code: 6100201

Issuer Information

Exchange: NSC
CEO: Fredric D. Price
Employees: 2
NAICS: Pharmaceutical Preparation Manufacturing (325412)
(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 9 9 9 9
Low Target Price Estimate 9 9 9 9
Mean Target Price Estimate 9 9 9 9
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 12/09/16 12/09/16 12/09/16 12/09/16
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 0 0 0 1